![No image](https://static.cymitquimica.com/public/img/logo-cymit-gray.png)
CAS: 879507-25-2
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | NRC-AN-019 REF: 3D-EKB50725CAS: 879507-25-2 | Min. 95% | To inquire | Tue 15 Apr 25 |
![]() | AN-019 REF: TM-T26625CAS: 879507-25-2 | 98.01% | 279.00 €~2,375.00 € | Tue 22 Apr 25 |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
NRC-AN-019
CAS:879507-25-2
NRC-AN-019 is an imatinib-resistant drug that belongs to the class of bcr-abl inhibitors. It has …
Formula:
C25H17F6N5O
Purity:
Min. 95%
Molecular weight:
517.4 g/mol
Ref: 3D-EKB50725
10mg | 963.00 € | ||
25mg | 1,477.00 € | ||
50mg | 2,363.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
AN-019
CAS:879507-25-2
AN-019 (NRC-019) is a Bcr-Abl kinase inhibitor with antitumor activity for the study of chronic …
Formula:
C25H17F6N5O
Purity:
98.01%
Color and Shape:
Solid
Molecular weight:
517.43
Ref: TM-T26625
1mg | 279.00 € | ||
5mg | 685.00 € | ||
10mg | 938.00 € | ||
25mg | 1,444.00 € | ||
50mg | 1,882.00 € | ||
100mg | 2,375.00 € |
Estimated delivery in United States, on Tuesday 22 Apr 2025